Synergistic Medication Management System
Legal Citation
Summary of the Inventive Concept
A comprehensive system integrating AI, IoT, blockchain, and wearable technologies to monitor and manage medication regimes, assess driving ability, and provide personalized recommendations, ensuring enhanced safety and adherence.
Background and Problem Solved
The original patent disclosed a device for managing a medication regime, focusing on monitoring injection devices and assessing driving ability. However, it lacked the integration of emerging technologies to provide a more robust and connected system. The new inventive concept addresses this limitation by combining distinct technologies to create a more powerful system, enabling real-time monitoring, secure data storage, and personalized insights.
Detailed Description of the Inventive Concept
The Synergistic Medication Management System comprises a wearable device tracking a user's physiological condition, an AI-powered analytics module predicting impairment levels, and a blockchain-based secure storage for recording medication history and impairment levels. The system integrates with IoT-enabled injection devices, transmitting dosing information to a cloud-based server for analysis. A mobile application provides personalized alerts and recommendations to the user, while a smart notification system alerts the user and healthcare provider of potential non-adherence. The system's AI-driven analytics module identifies patterns of non-adherence, enabling targeted interventions.
Novelty and Inventive Step
The new inventive concept's novelty lies in the synergistic integration of AI, IoT, blockchain, and wearable technologies to create a comprehensive medication management system. The inventive step is the combination of these distinct technologies to provide real-time monitoring, secure data storage, and personalized insights, enhancing safety and adherence.
Alternative Embodiments and Variations
Alternative embodiments could include integrating the system with other healthcare devices, such as glucose monitors or insulin pumps, or incorporating additional AI-powered features, like predictive analytics for medication side effects. Variations could include adapting the system for different medical conditions or developing a more portable, compact version of the wearable device.
Potential Commercial Applications and Market
The Synergistic Medication Management System has significant commercial potential in the healthcare and pharmaceutical industries, particularly in the areas of medication adherence, patient safety, and personalized medicine. Target markets could include patients with chronic diseases, healthcare providers, and pharmaceutical companies seeking to improve medication outcomes and reduce healthcare costs.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device monitoring, medication management systems, and vehicle safety technologies with a focus on physiological tracking and impairment assessment
Person of Ordinary Skill (PHOSITA) Profile
A professional with expertise in biomedical engineering, IoT systems, and medical device integration, possessing knowledge of sensor technologies, data analytics, and healthcare monitoring platforms
Obviousness Rationale
A PHOSITA would recognize that the PTD represents a predictable extension of the source patent's core concept of monitoring medication and driving ability by incorporating emerging technologies like AI, blockchain, and IoT. The fundamental approach of tracking physiological conditions and medication dosing to assess impairment remains consistent, with the PTD merely applying known technological integration techniques to enhance the original system's capabilities.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,325 |
|---|---|
| Title | Device for managing a medication regime |
| Assignee(s) | Sanofi |